The article discusses on how oncology nurses can help patients understand which clinical trials listed on their test results might be an option for them. It highlights that Testing can identify inherited DNA changes (germline) that increase a person's cancer risk, but it can also uncover acquired changes in a tumor (somatic) and help suggest therapies that could target the driver variant that is leading to cancer growth.